AXIM BIOTECHNOLOGIES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 382.73 million shares for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 370.38M shares, a 99.38% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 185.77M shares, a 292.75% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 47.30M shares, a 57.03% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-03-31 was 30.12M shares.
- AXIM BIOTECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 47.30M shares, a 54.92% increase from fiscal 2021.
- AXIM BIOTECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 30.53M shares, a 6.22% decline from fiscal 2020.
- AXIM BIOTECHNOLOGIES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 32.56M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-06-30 | 382.73M shares 10-Q · filed 2024-08-19 | |||||
| 2024-03-31 | 370.38M shares 10-Q/A · filed 2024-05-22 | |||||
| 2023-12-31 | 185.77M shares 10-Q/A · filed 2024-05-22 | 250.03M shares 10-K · filed 2024-04-16 | ||||
| 2023-09-30 | 254.74M shares 10-Q · filed 2023-11-20 | |||||
| 2023-06-30 | 234.22M shares 10-Q · filed 2024-08-19 | |||||
| 2023-03-31 | 185.77M shares 10-Q · filed 2023-05-22 | |||||
| 2022-12-31 | 47.30M shares 10-K · filed 2024-04-16 | |||||
| 2022-09-30 | 47.14M shares 10-Q/A · filed 2022-11-15 | |||||
| 2022-06-30 | 49.25M shares 10-Q · filed 2022-08-16 | |||||
| 2022-03-31 | 47.30M shares 10-Q · filed 2023-05-22 | 45.45M shares 10-Q · filed 2022-05-23 | ||||
| 2021-12-31 | 30.53M shares 10-K · filed 2023-04-17 | 30.12M shares 10-K/A · filed 2022-04-19 | ||||
| 2021-09-30 | 30.53M shares 10-Q · filed 2021-11-22 | |||||
| 2021-06-30 | 30.34M shares 10-Q · filed 2021-08-23 | |||||
| 2021-03-31 | 30.12M shares 10-Q · filed 2022-05-23 | |||||
| 2020-12-31 | 32.56M shares 10-K/A · filed 2022-04-19 |